The TETAMI Trial: The safety and efficacy of subcutaneous enoxaparin versus intravenous unfractionated heparin and of tirofiban versus placebo in the treatment of acute myocardial infarction for patients not thrombolyzed: Methods and design - Cohen, M; Maritz, F; Franco, GG; Danchin, N; Timerman, A; Huber, K (J Thromb Thrombolysis, 2000)